Reviewed by Michael Gill, B. Sc.
16 Social Anxiety Clinical Trials Near Me
Top Hospitals for Social Anxiety Clinical Trials
Image of The Medical Research Network, LLC in New York.
The Medical Research Network, LLC
New York
3Active Trials
0All Time Trials for Social Anxiety
2012First Social Anxiety Trial
Image of EPI-CBD-001 Site in California.
EPI-CBD-001 Site
Encino
1Active Trials
0All Time Trials for Social Anxiety
2022First Social Anxiety Trial
Top Cities for Social Anxiety Clinical Trials
Image of Miami in Florida.
Miami
3Active Trials
PREVAIL Study Clinical Trial SiteTop Active Site
Most Recent Social Anxiety Clinical Trials
Top Treatments for Social Anxiety Clinical Trials
Treatment Name
Active Social Anxiety Clinical Trials
All Time Trials for Social Anxiety
First Recorded Social Anxiety Trial
Cannabidiol (CBD) Oral Solution 300 mg/day
1
1
2022
Cannabidiol 400mg
1
1
2022
Low dose RLS103
1
1
2022
Cariprazine
1
1
2022
225 mg BNC210
1
1
2022

What Are Social Anxiety Clinical Trials?

Social anxiety is the persistent fear of being judged and watched by others. Individuals with social anxiety disorder deal with irrational embarrassment, self-consciousness, fear, and anxiety over their daily interactions.

This chronic disorder affects all aspects of an individual’s life, making it hard for them to perform everyday activities. The symptoms include excessively fearing being judged, worrying about concern, humiliation, or embarrassment about offending others.

Clinical trials help find innovative treatments and therapies to help individuals with social anxiety manage the symptoms. With the lack of research and trials related to clinical trials, it is essential to make headway in new interventions for social anxiety disorder.

Why Is Social Anxiety Being Studied Through Clinical Trials?

Around 12.1% of adults in the US deal with a social anxiety disorder at least once in their lifetime. According to NIMH: Social Anxiety Disorder, this disorder affects 15 million individuals annually in the country.

Social anxiety disorder is common in both women and men, usually beginning at an early age of 13. Around 36% of individuals with this disorder seek professional help after experiencing the symptoms for over 10 years.

Research is greatly needed for social anxiety treatment to find innovative ways to treat this disorder. Currently, research and clinical trials for anxiety disorder are lagging behind the research for other mental health disorders, like schizophrenia, bipolar disorder, and depressive disorder.

What Are The Types of Treatments Available For Social Anxiety?

Psychotherapy is the most common treatment for this order, combined with certain medications to help with the symptoms. Teletherapy is another effective solution for individuals with severe social anxiety disorder. They can benefit from therapy without the need to go out.

Aside from therapy, multiple online and local support groups are also available for individuals with social anxiety. These support groups connect individuals with social anxiety to help and support one another.

Medications are another major treatment for social anxiety disorder. SSRI antidepressants (Selective Serotonin Reuptake Inhibitors) are usually prescribed to treat social anxiety, including:

  • Fluoxetine 
  • Sertraline 
  • Paroxetine 

Some patients are also prescribed SNRI antidepressants (Selective Serotonin and Norepinephrine Reuptake Inhibitors), depending on the severity of their condition. These might include:

  • Venlafaxine 
  • Duloxetine 

What Are Some Recent Breakthrough Clinical Trials For Social Anxiety?

There haven't been many breakthrough clinical trials for social anxiety disorder since most researchers focus on finding treatments for other significant conditions. The only recent breakthrough clinical trial for social anxiety is as follows:

2019: VistaGen Therapeutics developed the latest generation medication for the disorders and diseases of the central nervous system, including social anxiety disorder, in their clinical trial. The medication has been approved by FDA and earned the Fast Track designation. The nasal spray, PH94B, is a rapid-onset and odorless spray that can treat social anxiety disorder.

This is the first-of-its-kind spray for this disorder that also has the potential to help other anxiety disorders, including generalized anxiety, panic disorder, post-traumatic stress disorder, pre or post-operative anxiety, and perinatal anxiety. This spray can activate the nasal chemosensory receptors, which suppress anxiety and fear linked to everyday work and social situations. The company is initiating the third phase of PH94B clinical development.

Who Are Some Of The Key Opinion Leaders / Researchers / Institutions Conducting Social Anxiety Clinical Trials Research?

National Social Anxiety Center (NSAC): This foundation is dedicated to providing the latest research and clinical trials on social anxiety disorder treatments. The members aim to enhance the care and treatment of social anxiety through collaboration and sharing clinical work and clinical experiences to enrich the overall scientific process.

The Social Anxiety Association (SAA): It is a nonprofit foundation dedicated to tending to the increasing need of individuals with social anxiety disorder. The organization focuses on spreading social anxiety awareness and the available treatment options. It also is a major information center and resource for social anxiety-related matters.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 28th, 2021

Last Reviewed: November 30th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Danforth AL, Struble CM, Yazar-Klosinski B, Grob CS. MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:237-49. doi: 10.1016/j.pnpbp.2015.03.011. Epub 2015 Mar 25. https://pubmed.ncbi.nlm.nih.gov/258182462 Danforth AL, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L, Yazar-Klosinski B, Emerson A. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology (Berl). 2018 Nov;235(11):3137-3148. doi: 10.1007/s00213-018-5010-9. Epub 2018 Sep 8. https://pubmed.ncbi.nlm.nih.gov/301963973 Luoma JB, Shahar B, Kati Lear M, Pilecki B, Wagner A. Potential processes of change in MDMA-Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self-transcendence, and therapeutic relationships. Hum Psychopharmacol. 2022 May;37(3):e2824. doi: 10.1002/hup.2824. Epub 2021 Nov 5. Review. https://pubmed.ncbi.nlm.nih.gov/347391654 Luoma JB, Shahar B, Kati Lear M, Pilecki B, Wagner A. Potential processes of change in MDMA-Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self-transcendence, and therapeutic relationships. Hum Psychopharmacol. 2021 Nov 5:e2824. doi: 10.1002/hup.2824. [Epub ahead of print] Review. https://pubmed.ncbi.nlm.nih.gov/347391655 Luoma JB, Shahar B, Kati Lear M, Pilecki B, Wagner A. Potential processes of change in MDMA-Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self-transcendence, and therapeutic relationships. Hum Psychopharmacol. 2022 May;37(3):e2824. doi: 10.1002/hup.2824. Epub 2021 Nov 5. https://pubmed.ncbi.nlm.nih.gov/347391656 Luoma J, Lear MK. MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder. Front Psychiatry. 2021 Sep 27;12:733893. doi: 10.3389/fpsyt.2021.733893. eCollection 2021. Review. https://pubmed.ncbi.nlm.nih.gov/346461767 Careri JM, Draine AE, Hanover R, Liebowitz MR. A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder. Prim Care Companion CNS Disord. 2015 Nov 26;17(6). doi: 10.4088/PCC.15m01831. eCollection 2015. https://pubmed.ncbi.nlm.nih.gov/270574148 Luoma J, Lear MK. MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder. Front Psychiatry. 2021 Sep 27;12:733893. doi: 10.3389/fpsyt.2021.733893. eCollection 2021. https://pubmed.ncbi.nlm.nih.gov/34646176